Whilst an in-depth mechanistic study of HMGCS1-mediated transcriptional effects, lies beyond the scope of this article, the evidence strongly suggests, that HMGCS1 has genuine potential as a therapeutic target, especially in aggressive and basal breast cancer populations. The gene discussed is HMGCS1; the disease is breast carcinoma.